Terms: = Bone cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
202 results:
1. Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapy.
Weng G; Huang J; An N; Zhang Y; Yu G; Sun Z; Lin D; Deng L; Liang X; Xiao J; Zhang H; Guo Z; He X; Jin H; Liu Q; Du X
Cancer Med; 2024 Jan; 13(2):e6885. PubMed ID: 38334500
[TBL] [Abstract] [Full Text] [Related]
2. RUNX1/npm1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma.
Cui X; Huo D; Wang Q; Wang Y; Liu X; Zhao K; You Y; Zhang J; Kang C
Cell Death Dis; 2024 Jan; 15(1):98. PubMed ID: 38286983
[TBL] [Abstract] [Full Text] [Related]
3. Droplet digital PCR for sensitive relapse detection in acute myeloid leukaemia patients transplanted by reduced intensity conditioning.
Gronlund JK; Veigaard C; Juhl-Christensen C; Skou AS; Melsvik D; Ommen HB
Eur J Haematol; 2024 Apr; 112(4):601-610. PubMed ID: 38197567
[TBL] [Abstract] [Full Text] [Related]
4. Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Moukalled N; Labopin M; Versluis J; Socié G; Blaise D; Salmenniemi U; Rambaldi A; Gedde-Dahl T; Tholouli E; Kröger N; Bourhis JH; Von Dem Borne P; Daguindau E; Forcade E; Nagler A; Esteve J; Ciceri F; Bazarbachi A; Mohty M
Am J Hematol; 2024 Mar; 99(3):360-369. PubMed ID: 38165072
[TBL] [Abstract] [Full Text] [Related]
5. Acute onset of leukemia cutis in a 70-year-old-patient: a case report.
Selan M; Stopajnik N
Acta Dermatovenerol Alp Pannonica Adriat; 2023 Dec; 32(4):187-189. PubMed ID: 38126102
[TBL] [Abstract] [Full Text] [Related]
6. Understanding differential technologies for detection of MRD and how to incorporate into clinical practice.
Cloos J; Ngai LL; Heuser M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):682-690. PubMed ID: 38066915
[TBL] [Abstract] [Full Text] [Related]
7. Blasts with folded nuclei: A histopathologic finding in myeloid leukemia cutis with npm1 and FLT3 mutations.
Han S; Patel T; Garcia ML; Tirado M
J Cutan Pathol; 2024 Feb; 51(2):130-134. PubMed ID: 37866827
[TBL] [Abstract] [Full Text] [Related]
8. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.
Nelde A; Schuster H; Heitmann JS; Bauer J; Maringer Y; Zwick M; Volkmer JP; Chen JY; Stanger AMP; Lehmann A; Appiah B; Märklin M; Rücker-Braun E; Salih HR; Roerden M; Schroeder SM; Häring MF; Schlosser A; Schetelig J; Schmitz M; Boerries M; Köhler N; Lengerke C; Majeti R; Weissman IL; Rammensee HG; Walz JS
Blood Cancer Discov; 2023 Nov; 4(6):468-489. PubMed ID: 37847741
[TBL] [Abstract] [Full Text] [Related]
9. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With bone Marrow.
Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
[TBL] [Abstract] [Full Text] [Related]
10. Molecular MRD is strongly prognostic in patients with npm1-mutated AML receiving venetoclax-based nonintensive therapy.
Othman J; Tiong IS; O'Nions J; Dennis M; Mokretar K; Ivey A; Austin M; Latif AL; Amer M; Chan WY; Crawley C; Crolla F; Cross J; Dang R; Elliot J; Fong CY; Galli S; Gallipoli P; Hogan F; Kalkur P; Khan A; Krishnamurthy P; Laurie J; Loo S; Marshall S; Mehta P; Murthy V; Nagumantry S; Pillai S; Potter N; Sellar R; Taylor T; Zhao R; Russell NH; Wei AH; Dillon R
Blood; 2024 Jan; 143(4):336-341. PubMed ID: 37647641
[TBL] [Abstract] [Full Text] [Related]
11. Stereotactic Body Radiotherapy for Lymph-Nodal Oligometastatic Prostate cancer: A Multicenter Retrospective Experience.
Cuccia F; Tamburo M; Piras A; Mortellaro G; Iudica A; Daidone A; Federico M; Zagardo V; Ferini G; Marletta F; Spatola C; Fazio I; Filosto S; Pergolizzi S; Ferrera G
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629732
[No Abstract] [Full Text] [Related]
12. Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type npm1: A Report from the EBMT Acute Leukemia Working Party.
Bazarbachi A; Labopin M; Gedde-Dahl T; Remenyi P; Forcade E; Kröger N; Socié G; Craddock C; Bourhis JH; Versluis J; Yakoub-Agha I; Salmenniemi U; El-Cheikh J; Bug G; Esteve J; Nagler A; Ciceri F; Mohty M
Clin Cancer Res; 2023 Nov; 29(21):4441-4448. PubMed ID: 37603683
[TBL] [Abstract] [Full Text] [Related]
13. Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT.
Sanz J; Labopin M; Pabst T; Versluis J; Van Gorkom G; Meijer E; Gedde-Dahl T; Montoro J; Arcese W; Pérez-Simón JA; Schaap N; Maertens J; Vrhovac R; Lanza F; Gorin NC; Mohty M; Ciceri F
Bone Marrow Transplant; 2023 Nov; 58(11):1197-1202. PubMed ID: 37553468
[TBL] [Abstract] [Full Text] [Related]
14. Molecular and clinical significance of FLT3, npm1, DNMT3A and TP53 mutations in acute myeloid leukemia patients.
Ali AM; Salih GF
Mol Biol Rep; 2023 Oct; 50(10):8035-8048. PubMed ID: 37540457
[TBL] [Abstract] [Full Text] [Related]
15. Phenotypic clues that predict underlying cytogenetic/genetic abnormalities in myeloid malignancies: A contemporary review.
Stone M; Lilley CM; Tang G; Loghavi S; Mirza KM
Cytopathology; 2023 Nov; 34(6):530-541. PubMed ID: 37522274
[TBL] [Abstract] [Full Text] [Related]
16. A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML.
Chen L; Pronk E; van Dijk C; Bian Y; Feyen J; van Tienhoven T; Yildirim M; Pisterzi P; de Jong MME; Bastidas A; Hoogenboezem RM; Wevers C; Bindels EM; Löwenberg B; Cupedo T; Sanders MA; Raaijmakers MHGP
Blood Cancer Discov; 2023 Sep; 4(5):394-417. PubMed ID: 37470778
[TBL] [Abstract] [Full Text] [Related]
17. Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories.
Borate U; Yang F; Press R; Ruppert AS; Jones D; Caruthers S; Zhao W; Vergilio JA; Pavlick DC; Juckett L; Norris B; Bucy T; Burd A; Stein EM; Patel P; Baer MR; Stock W; Schiller G; Blum W; Kovacsovics T; Litzow M; Foran J; Heerema NA; Rosenberg L; Marcus S; Yocum A; Stefanos M; Druker B; Byrd JC; Levine RL; Mims A
Blood Adv; 2023 Oct; 7(20):6048-6054. PubMed ID: 37459200
[TBL] [Abstract] [Full Text] [Related]
18. Hypoplastic form of myelodysplastic neoplasm.
Votavová H; Lenertová Z; Votava T; Beličková M
Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
[TBL] [Abstract] [Full Text] [Related]
19. Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.
Zarnegar-Lumley S; Alonzo TA; Gerbing RB; Othus M; Sun Z; Ries RE; Wang J; Leonti A; Kutny MA; Ostronoff F; Radich JP; Appelbaum FR; Pogosova-Agadjanyan EL; O'Dwyer K; Tallman MS; Litzow M; Atallah E; Cooper TM; Aplenc RA; Abdel-Wahab O; Gamis AS; Luger S; Erba H; Levine R; Kolb EA; Stirewalt DL; Meshinchi S; Tarlock K
Blood Adv; 2023 Oct; 7(19):5941-5953. PubMed ID: 37267439
[TBL] [Abstract] [Full Text] [Related]
20. HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for npm1-Mutated Acute Myeloid Leukemia.
Narayan R; Niroula A; Wang T; Kuxhausen M; He M; Meyer E; Chen YB; Bhatt VR; Beitinjaneh A; Nishihori T; Sharma A; Brown VI; Kamoun M; Diaz MA; Abid MB; Askar M; Kanakry CG; Gragert L; Bolon YT; Marsh SGE; Gadalla SM; Paczesny S; Spellman S; Lee SJ
Transplant Cell Ther; 2023 Jul; 29(7):452.e1-452.e11. PubMed ID: 36997024
[TBL] [Abstract] [Full Text] [Related]
[Next]
